Disc Medicine to Present at the 44th Annual J.P. Morgan Healthcare Conference
Disc Medicine (NASDAQ:IRON) announced that John Quisel, J.D., Ph.D., President and Chief Executive Officer, will present at the 44th Annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Disc Medicine (NASDAQ:IRON) announced that John Quisel, J.D., Ph.D., President and Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 3:00 pm PT / 6:00 pm ET. A live webcast will be available via the company's investor relations website at ir.discmedicine.com, and an archived replay will be posted after the event.
Details
News Market Reaction – IRON
On Jan 7, the day this news came out, IRON closed 4.63% above the previous close.
Data tracked by StockTitan Argus for the Jan 7 session.
Key Figures
- Conference edition
- 44th Annual
- J.P. Morgan Healthcare Conference
- Presentation date
- January 14
- Conference corporate presentation date
- Presentation time PT
- 3:00 pm PT
- Scheduled conference presentation time
- Presentation time ET
- 6:00 pm ET
- Scheduled conference presentation time
Historical Context
-
Q3 2025 results, NDA submission for bitopertin, runway extended into 2029.
-
Announcement of upcoming ASH Phase 2 data presentations for DISC-0974 and DISC-3405.
-
Participation in multiple November 2025 investor conferences with webcast access.
-
Pricing of $250M upsized public offering of common stock and pre-funded warrants.
-
Announcement of proposed $220M common stock and pre-funded warrant offering.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
clinical-stage medical
hematologic medical
webcast technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
WATERTOWN, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that John Quisel, J.D., Ph.D., President and Chief Executive Officer, will give a corporate presentation at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14th at 3:00 pm PT / 6:00 pm ET.
A live webcast of the presentation will be available through the investor relations section of the Company's website at ir.discmedicine.com and an archived replay will be available after the event.
About Disc Medicine
Disc Medicine (NASDAQ:IRON) is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing novel treatments for patients who suffer from serious hematologic diseases. We are building a portfolio of innovative, potentially first-in-class therapeutic candidates that aim to address a wide spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, specifically heme biosynthesis and iron homeostasis. For more information, please visit www.discmedicine.com.
Media Contact
Peg Rusconi
Deerfield Group
peg.rusconi@deerfieldgroup.com
Investor Relations Contact
Christina Tartaglia
Precision AQ
christina.tartaglia@precisionaq.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.